HomeBUSINESS
BUSINESS

Mochida Licenses EPA Technologies to Amarin
(Jun.13.2018)

Mochida Pharmaceutical is granting rights for its omega-3 acid EPA (eicosapentaenoic acid) technologies to Ireland-based Amarin for the development and commercialization of EPA-based drug products in the US and certain other territories, the two companies said on June 12 ...
(LOG IN FOR FULL STORY)